Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Limited has announced a new application for the quotation of securities, specifically 11,792 ordinary fully paid shares under the ASX security code TLX, issued on September 2, 2024. This move, indicative of the company’s growth strategy, is set to attract investors’ attention in the financial markets.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
